IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
